Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...